Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05964907 · ClinicalTrials.gov registry record · NA

Optimizing Phototesting and Investigating Photobiology of Visible Light

A NA study of Healthy, sponsored by Henry Ford Health System.

Active
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT05964907 is a NA study of Healthy that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 14 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05964907, a NA study of Healthy, is active but no longer recruiting, sponsored by Henry Ford Health System.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

Specific Aim 1: To determine the impact of spectral composition of the VL+UVA1 source on the associated biologic effects. Specific Aim 2: To investigate differential responses of subjects with different skin phototypes to VL+UVA1, including immediate and delayed erythema and pigmentation, and photodamage.

Conditions Studied

Interventions

  • DEVICE Light Source B: Visible Light solar simulator (VL + UVA1)
  • DEVICE Light Source A: Visible Light solar simulator closer match to sunlight (VL +UVA1)

Study Locations (1)

Michigan

  • Henry Ford Medical Center - Detroit

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2021-10-06
Est. Completion 2026-12-30
Phase NA

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT05964907

The ClinicalTrials.gov registry entry for NCT05964907 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Light Source B: Visible Light solar simulator (VL + UVA1) is the first listed.

NCT05964907 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05964907 about?

NCT05964907 is a clinical study titled "Optimizing Phototesting and Investigating Photobiology of Visible Light". Specific Aim 1: To determine the impact of spectral composition of the VL+UVA1 source on the associated biologic effects. Specific Aim 2: To investigate differential responses of subjects with different skin phototypes to VL+UVA1, including immediate and delayed erythema and pigmentation, and photo...

What is the current status of trial NCT05964907?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2021-10-06. Estimated completion is 2026-12-30.

What conditions does trial NCT05964907 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05964907?

The interventions under investigation include: Light Source B: Visible Light solar simulator (VL + UVA1) (DEVICE), Light Source A: Visible Light solar simulator closer match to sunlight (VL +UVA1) (DEVICE).

Who is sponsoring clinical trial NCT05964907?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05964907 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.